Abayon, Romeo L.

HRN: 22-11-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/24/2022
10/31/2022
IVT
500mg
Q8hours
Indirect Hernia
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: